Autonomix Medical (AMIX) Cash from Financing Activities (2023 - 2025)

Autonomix Medical (AMIX) has reported Cash from Financing Activities for 3 consecutive years, with $5.4 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Cash from Financing Activities fell 39.46% year-over-year to $5.4 million in Q4 2025; TTM through Dec 2025 was $19.0 million, a 18.77% decrease from a year earlier, with the FY2024 full-year figure at $14.4 million, up 2034.81% from the prior year.
• Cash from Financing Activities was $5.4 million for Q4 2025 at Autonomix Medical, up from $2.7 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $14.4 million in Q1 2024 and troughed at $350000.0 in Q3 2023.
• A 3-year average of $4.8 million and a median of $2.7 million in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities surged 2034.81% in 2024 and slumped 39.46% in 2025, its largest moves.
• Over 3 years, Cash from Financing Activities stood at $1.6 million in 2023, then soared by 445.53% to $9.0 million in 2024, then tumbled by 39.46% to $5.4 million in 2025.
• The last three Cash from Financing Activities figures came in at $5.4 million (Q4 2025), $2.7 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.